AMELIA WITHINGTON: Open Payments
NPI 1659323228 · PHILA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 8 payments from 6 companies in 2025. Trend: 2023 $123 · 2024 $669 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $230 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| UCB, Inc. | 1 | $78 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: CAPLYTA, COBENFY, Fintepla, AUSTEDO XR, VRAYLAR, REXULTI.
Industry payments across PA — which companies pay providers there.
